AG636 treatment similarly caused downregulation of YY1 protein, but not a transcript, in human AML cell lines MOLM13 and OCI‐AML3 (Fig 5F and Appendix Fig S5F). The gene discussed is RUNX2; the disease is acute myeloid leukemia.